We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBRT icon
3376
Liberty Energy
LBRT
$3.45B
$222K ﹤0.01%
17,507
MSEX icon
3377
Middlesex Water
MSEX
$1.11B
$222K ﹤0.01%
+2,877
New +$258K
POWW icon
3378
Outdoor Holding Co
POWW
$255M
$222K ﹤0.01%
75,620
+1,500
+2% +$6.41K
XPH icon
3379
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
$222K ﹤0.01%
+5,517
New +$236K
FLN icon
3380
First Trust Latin America AlphaDEX Fund
FLN
$35.7M
$221K ﹤0.01%
14,130
-13,413
-49% -$227K
JRVR icon
3381
James River Group Holdings
JRVR
$200M
$221K ﹤0.01%
+9,683
New +$231K
PRDO icon
3382
Perdoceo Education
PRDO
$1.99B
$221K ﹤0.01%
21,451
+149
+0.7% +$1.78K
PROF
3383
Profound Medical
PROF
$242M
$221K ﹤0.01%
54,611
-6,870
-11% -$46.4K
BA icon
3384
PUT
Boeing
BA
$182B
$220K ﹤0.01%
7,500
GGME icon
3385
Invesco Next Gen Media and Gaming ETF
GGME
$46.9M
$220K ﹤0.01%
6,949
-405
-6% -$14.8K
IBMQ icon
3386
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
$663M
$219K ﹤0.01%
9,054
-2,943
-25% -$74K
PRNT icon
3387
The 3D Printing ETF
PRNT
$65.5M
$219K ﹤0.01%
11,067
-3,909
-26% -$86.8K
SIVR icon
3388
abrdn Physical Silver Shares ETF
SIVR
$4.47B
$219K ﹤0.01%
11,962
-2,170
-15% -$40.1K
CBH
3389
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$219K ﹤0.01%
25,834
AM icon
3390
Antero Midstream
AM
$10.5B
$218K ﹤0.01%
23,791
-87,306
-79% -$860K
NPK icon
3391
National Presto Industries
NPK
$987M
$217K ﹤0.01%
+3,329
New +$230K
NRO
3392
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
$217K ﹤0.01%
67,131
+3,715
+6% +$14.4K
SWBI icon
3393
Smith & Wesson
SWBI
$643M
$217K ﹤0.01%
20,944
-28,449
-58% -$376K
ABMD
3394
DELISTED
Abiomed Inc
ABMD
$217K ﹤0.01%
884
-2,067
-70% -$558K
MIDD icon
3395
Middleby
MIDD
$5.29B
$216K ﹤0.01%
1,682
-11,141
-87% -$1.56M
NRK icon
3396
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$930M
$216K ﹤0.01%
22,026
+1,562
+8% +$17.2K
SITC icon
3397
SITE Centers
SITC
$158M
$216K ﹤0.01%
25,807
-55
-0.2% -$575
RKLB icon
3398
Rocket Lab Corp
RKLB
$51.2B
$215K ﹤0.01%
52,856
-15,223
-22% -$75.1K
SJT
3399
San Juan Basin Royalty Trust
SJT
$129M
$215K ﹤0.01%
22,841
-13,486
-37% -$159K
FL
3400
DELISTED
Foot Locker
FL
$214K ﹤0.01%
+6,879
New +$220K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.